HMOX1 and Parkinson disease: Thus, considering the neuroprotective role of the Nrf2/HO-1 pathway, pharmacological modulation of the activation of Nrf2/HO-1 may represent a novel therapeutic target for the treatments of PD (Cuadrado et al., 2018).